Who
John K. A. Prendergast
Director
Company insider
Files Form 4 as: Director, Palatin Technologies; Director, NightHawk Biosciences; Director, MediciNova; Director, Avigen Inc \de; Director, Avax Technologies.
In numbers
- Trades disclosed
- 105
- Buys
- 2
- Sells
- 5
- Bought
- $78K
- Sold
- $310K
- Companies
- 5
- Companies where not an officer
- 5
- First trade
- 7 Jun 2005
- Last trade
- 3 Aug 2026
- Last filed
- 5 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Aug 2026filed 5 Aug 2026 | PTN Palatin Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code Z | —2,900 at $0.00 | filing |
| 3 Aug 2026filed 5 Aug 2026 | PTN Palatin Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code Z | —2,900 at $0.00 | filing |
| 9 Dec 2025filed 11 Dec 2025 | PTN Palatin Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,600 at $0.00 | filing |
| 9 Dec 2025filed 11 Dec 2025 | PTN Palatin Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,600 at $0.00 | filing |
| 9 Dec 2025filed 11 Dec 2025 | PTN Palatin TechnologiesBiotechnology | SEC FORM 4 Code A | —1,300 at $0.00 | filing |
| 9 Dec 2025filed 11 Dec 2025 | PTN Palatin TechnologiesBiotechnology | SEC FORM 4 Code A | —1,300 at $0.00 | filing |
| 15 Jul 2024filed 16 Jul 2024 | PTN Palatin Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code Z | —23,000 at $0.00 | filing |
| 15 Jul 2024filed 16 Jul 2024 | PTN Palatin TechnologiesBiotechnology | SEC FORM 4 Code A | —16,000 at $0.00 | filing |
| 20 Jun 2023filed 22 Jun 2023 | PTN Palatin Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 20 Jun 2023filed 22 Jun 2023 | PTN Palatin TechnologiesBiotechnology | SEC FORM 4 Code A | —13,000 at $0.00 | filing |
| 7 Dec 2022filed 9 Dec 2022 | NightHawk Biosciencesoption or derivative | SEC FORM 4 Code A | —203,921 at $0.00 | filing |
| 22 Jun 2022filed 24 Jun 2022 | PTN Palatin Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code A | —173,000 at $0.00 | filing |
| 22 Jun 2022filed 24 Jun 2022 | PTN Palatin TechnologiesBiotechnology | SEC FORM 4 Code A | —99,000 at $0.00 | filing |
| 30 Dec 2021filed 3 Jan 2022 | Heat Biologicsoption or derivative | SEC FORM 4 Code J | —129,820 at $0.00 | filing |
| 30 Dec 2021filed 3 Jan 2022 | Heat Biologicsoption or derivative | SEC FORM 4 Code A | —129,820 at $0.00 | filing |
| 13 Dec 2021filed 15 Dec 2021 | Heat Biologicsoption or derivative | SEC FORM 4 Code A | —129,820 at $0.00 | filing |
| 22 Jun 2021filed 24 Jun 2021 | PTN Palatin TechnologiesBiotechnology | SEC FORM 4 Code A | —105,000 at $0.00 | filing |
| 22 Jun 2021filed 24 Jun 2021 | PTN Palatin Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code A | —173,000 at $0.00 | filing |
| 14 May 2021filed 18 May 2021 | Heat Biologics | SEC FORM 4 Sold | $205K35,000 at $5.87 | filing |
| 4 Jan 2021filed 6 Jan 2021 | Heat Biologics | SEC FORM 4 Code A | —138,272 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.